General Information of the Compound
Compound ID |
CP0019675
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
N-(3-methoxyphenyl)-4-{pyrazolo[1,5-a]pyridazin-3-yl}pyrimidin-2-amine
Show/Hide
|
||||||||||||||||||
Synonyms |
2-Pyrimidinamine, N-(3-methoxyphenyl)-4-pyrazolo[1,5-b]pyridazin-3-yl-
551920-54-8
AB01092291-01
AC1O6ZIQ
BDBM8128
CHEMBL187081
CTK1F7320
DA-42106
DTXSID60424889
FT-0707969
GW810576X
HMS3303K24
HMS3305F24
N-(3-methoxyphenyl)-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amine
NCGC00242229-01
PYRAZOLOPYRIDAZINE 1
SCHEMBL4489357
ZINC13582569
n-(3-methoxyphenyl)-4-pyrazolo[1,5-b]pyridazin-3-yl-2-pyrimidinamine
pyrazolo[1,5-b]pyridazine deriv. 19
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C17H14N6O
|
||||||||||||||||||
Molecular Weight |
318.34
|
||||||||||||||||||
Canonical SMILES |
COc1cccc(Nc2nccc(n2)-c2cnn3ncccc23)c1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C17H14N6O/c1-24-13-5-2-4-12(10-13)21-17-18-9-7-15(22-17)14-11-20-23-16(14)6-3-8-19-23/h2-11H,1H3,(H,18,21,22)
Show/Hide
|
||||||||||||||||||
InChIKey |
GBNWWXHUOVAUHT-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT03643, Glycogen synthase kinase-3 beta
Protein ID: PT00962, Glycogen synthase kinase-3 beta
Clinical Information about the Compound